Literature DB >> 22776164

Human menstrual blood-derived mesenchymal cells as a cell source of rapid and efficient nuclear reprogramming.

Deivid de Carvalho Rodrigues1, Karina Dutra Asensi, Leandro Vairo, Ricardo Luiz Azevedo-Pereira, Rosane Silva, Edson Rondinelli, Regina Coeli Goldenberg, Antonio Carlos Campos de Carvalho, Turán Péter Urményi.   

Abstract

Induced pluripotent stem cells (iPSCs) were originally generated by forced ectopic expression of four transcription factors genes-OCT4, KLF4, SOX2, and c-MYC-in fibroblasts. However, the efficiency of iPSCs obtention is extremely low, and reprogramming takes about 20 days. We reasoned that adult cells showing basal expression of core embryonic stem (ES) cell regulator genes could be a better cell source for reprogramming. Menstrual blood-derived mesenchymal cells (MBMCs) are multipotent cells that show detectable levels of some of the core ES cells regulators. The aim of this study was to determine whether reprogramming efficiency could be increased by using MBMCs as a cell source to generate iPSCs. MBMCs were transduced with recombinant retroviruses expressing the coding regions of OCT4, SOX2, and KLF4 genes. Cells with high nucleus/cytoplasm ratio can be detected about 5 days of posttransduction, and colonies of typical ES-like cells begun to appear after 7 days. At day 15, colonies were picked up and expanded for characterization. Most of the clones were morphologically identical to ES cells and positive at the mRNA and protein levels for all pluripotency markers tested. The clones are capable of forming embryoid bodies and to differentiate in vitro into cells of the three germ cell layers. Our results show that the reprogramming was faster and with efficiency around 2-5%, even in the absence of ectopic expression of c-MYC. To date, this is the first study showing MBMCs as a cell source for nuclear reprogramming.

Entities:  

Mesh:

Year:  2012        PMID: 22776164     DOI: 10.3727/096368912X653048

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  11 in total

Review 1.  Endometrial stem cells: clinical application and pathological roles.

Authors:  Yanping Xu; Huiting Zhu; Dongni Zhao; Jichun Tan
Journal:  Int J Clin Exp Med       Date:  2015-12-15

2.  Comparative effect of human platelet derivatives on proliferation and osteogenic differentiation of menstrual blood-derived stem cells.

Authors:  Somaieh Kazemnejad; Roghaieh Najafi; Amir Hassan Zarnani; Saman Eghtesad
Journal:  Mol Biotechnol       Date:  2014-03       Impact factor: 2.695

3.  Human Menstrual Blood-Derived Mesenchymal Cells as New Human Feeder Layer System for Human Embryonic Stem Cells.

Authors:  Danúbia Silva Dos Santos; Vanessa Carvalho Coelho de Oliveira; Karina Dutra Asensi; Leandro Vairo; Adriana Bastos Carvalho; Antonio Carlos Campos de Carvalho; Regina Coeli Dos Santos Goldenberg
Journal:  Cell Med       Date:  2014-03-03

4.  Comparative evaluation of differentiation potential of menstrual blood- versus bone marrow-derived stem cells into hepatocyte-like cells.

Authors:  Sayeh Khanjani; Manijeh Khanmohammadi; Amir-Hassan Zarnani; Mohammad-Mehdi Akhondi; Ali Ahani; Zahra Ghaempanah; Mohammad Mehdi Naderi; Saman Eghtesad; Somaieh Kazemnejad
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

5.  Reprogramming to a pluripotent state modifies mesenchymal stem cell resistance to oxidative stress.

Authors:  Karina D Asensi; Rodrigo S Fortunato; Danúbia S dos Santos; Thaísa S Pacheco; Danielle F de Rezende; Deivid C Rodrigues; Fernanda C P Mesquita; Tais H Kasai-Brunswick; Antonio C Campos de Carvalho; Denise P Carvalho; Adriana B Carvalho; Regina C dos S Goldenberg
Journal:  J Cell Mol Med       Date:  2014-02-14       Impact factor: 5.310

Review 6.  Adult stem cell transplantation: is gender a factor in stemness?

Authors:  Naoki Tajiri; Kelsey Duncan; Mia C Borlongan; Mibel Pabon; Sandra Acosta; Ike de la Pena; Diana Hernadez-Ontiveros; Diego Lozano; Daniela Aguirre; Stephanny Reyes; Paul R Sanberg; David J Eve; Cesar V Borlongan; Yuji Kaneko
Journal:  Int J Mol Sci       Date:  2014-08-28       Impact factor: 5.923

7.  Efficient gene delivery to human umbilical cord mesenchymal stem cells by cationized Porphyra yezoensis polysaccharide nanoparticles.

Authors:  Qingtong Yu; Jin Cao; Baoding Chen; Wenwen Deng; Xia Cao; Jingjing Chen; Yan Wang; Shicheng Wang; Jiangnan Yu; Ximing Xu; Xiangdong Gao
Journal:  Int J Nanomedicine       Date:  2015-11-18

Review 8.  Endometrial stem/progenitor cells: the first 10 years.

Authors:  Caroline E Gargett; Kjiana E Schwab; James A Deane
Journal:  Hum Reprod Update       Date:  2015-11-09       Impact factor: 15.610

9.  iPS-Derived Early Oligodendrocyte Progenitor Cells from SPMS Patients Reveal Deficient In Vitro Cell Migration Stimulation.

Authors:  Lidia Lopez-Caraballo; Jordi Martorell-Marugan; Pedro Carmona-Sáez; Elena Gonzalez-Munoz
Journal:  Cells       Date:  2020-07-29       Impact factor: 6.600

10.  Evidence for the existence of CD34+ angiogenic stem cells in human first-trimester decidua and their therapeutic for ischaemic heart disease.

Authors:  Long Bai; Lu Sun; Wei Chen; Kai-Yu Liu; Chun-Feng Zhang; Fei Wang; Gui-Huan Zhang; Ye Huang; Jing-Xuan Li; Ying Gao; Xin Sun; Wei Liu; Guo-Qing Du; Ren-Ke Li; Ming-Li Huang; Hai Tian
Journal:  J Cell Mol Med       Date:  2020-09-08       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.